Ariosa Diagnostics, Inc. v. Sequenom, Inc.: Federal Circuit Finds Not Patent Eligible Claims for Detecting Paternally Inherited Nucleic Acid

Fitzpatrick Case Update
June 12, 2015

On June 12, 2015, the Federal Circuit issued an opinion holding that claims directed to a method of detecting paternally inherited cell-free fetal DNA (“cffDNA”) in maternal plasma or serum are not patent eligible subject matter under 35 U.S.C. § 101. Ariosa Diagnostics, Inc. v. Sequenom, Inc., Nos. 2014-1139, 2014-1144 (June 12, 2015).

View Attachment (PDF)